Out-licensing: Gastrointestinal

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..10 of 48 - per page Next page
Order by

Cellophil(TM) Biomedical Polymer - New and superior biomedical polymers for a new standard in the medical device industry.

Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More

ORS effervescent tablet (Oral Rehydration Salts)

The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More

HESylation

Coupling drug substances with hydroxyethyl starch (HES) derivatives to improve pharmacokinetics and pharmacodynamics. More

Micro Fine, Dry Powder Pulmonary Drug Delivery Technology Suite

Researchers at the University of Western Ontario have developed a Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More

Drug delivery systems

New Active Ingredient + Innovative Drug Delivery System = Business Success More

Cripto-1 Represents a Biomarker for Chronic Inflammatory Diseases

Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More

Timerx Technology, Geminex, SyncroDose, and GastroDose

The matrix consists of two polysaccharides, xanthan and locus More

Desalazine Sodium: Anti-inflammatory agent, Phase II, indicated for the topical treatment of ulcerative colitis.

The molecule is an azo derivative of an active molecule (UR-12715, anti-TNFalpha and PAF antagonist ) and 5-aminosalicylic acid (5-ASA), the gold standard treatment for mild to moderate ulcerative colitis. More

1,2,4-Benzothiadiazine derivatives

1,2,4-benzothiadiazine derivatives useful for the treatment of endocrinological system diseases such as hyperinsulinaemia and diabetes. More

TNF-alpha Converting Enzyme Inhibitory Agents and Stimulatory Agents

This TACE inhibitory protein could be used as a new therapeutic agent against chronic inflammatory diseases that are mediated by TNF-alpha. More

Displaying 1..10 of 48 - per page Next page
Order by

Your selection

Therapeutic target: Gastrointestinal del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Therapeutic target: Appendicitis; Cholangitis, sclerosing; Colitis; Colitis, ulcerative; Constipation; Crohn's disease; Diarrhea; Dyspepsia; Electrolyte replacement; Emesis; Emesis, motion; Esophagitis; Flatulence; Food poisoning; Gastritis; Gastroesophageal reflux disorder; Gastrointestinal (other); Gastrointestinal secretions; Gastroprokinetic; Helicobacter pylori; Inflammatory bowel disease; Irritable bowel syndrome; Nausea; Pancreatitis; Ulcer; Ulcer, gastric; Ulcer, gastroduodenal; Ulcer, peptic
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us